Literature DB >> 20076851

Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study.

Silvia Charwat1, Irene Lang, Markus Dettke, Senta Graf, Noemi Nyolczas, Rayyan Hemetsberger, Sholeh Zamini, Aliasghar Khorsand, Heinz Sochor, Gerald Maurer, Dietmar Glogar, Mariann Gyöngyösi.   

Abstract

The aim of the sub-study of the MYSTAR randomised trial was to analyse the changes in myocardial perfusion in NOGA-defined regions of interest (ROI) with intramyocardial injections of autologous bone marrow mononuclear cells (BM-MNC) using an elaborated transformation algorithm. Patients with recent first acute myocardial infarction (AMI) and left ventricular (LV) ejection fraction (EF) between 30-45% received BM-MNC by intramyocardial followed by intracoronary injection 68 +/- 34 days post-AMI (pooled data of MYSTAR). NOGA-guided endocardial mapping and 99m-Sestamibi-SPECT (single photon emission computer tomography) were performed at baseline and at three months follow-up (FUP). ROI was delineated as a best polygon by connecting of injection points of NOGA polar maps. ROIs were projected onto baseline and FUP polar maps of SPECT calculating the perfusion severity of ROI. Infarct size was decreased (from 27.2 +/- 10.7% to 24.1 +/- 11.5%, p<0.001), and global EF increased (from 38 +/- 6.1% to 41.5 +/- 8.4%, p<0.001) three months after BM-MNC delivery. Analysis of ROI resulted in a significant increase in unipolar voltage (index of myocardial viability) (from 7.9 +/- 3.0 mV to 9.9 +/- 2.7 mV at FUP, p<0.001) and local linear shortening (index of local wall motion disturbances) (from 11.0 +/- 3.9% to 12.7 +/- 3.4%, p=0.01). NOGA-guided analysis of the intramyocardially treated area revealed a significantly increased tracer uptake both at rest (from 56.7 +/- 16.1% to 62.9 +/- 14.2%, p=0.003) and at stress (from 59.3 +/- 14.2% to 62.3 +/- 14.9%, p=0.01). Patients exhibiting >or=5% improvement in perfusion defect severity received a significantly higher number of intramyocardial BM-MNC. In conclusion, combined cardiac BM-MNC delivery induces significant improvement in myocardial viability and perfusion in the intramyocardially injected area.

Entities:  

Mesh:

Year:  2010        PMID: 20076851     DOI: 10.1160/TH09-08-0520

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

Review 1.  Stem cell therapy for chronic ischaemic heart disease and congestive heart failure.

Authors:  Sheila A Fisher; Carolyn Doree; Anthony Mathur; David P Taggart; Enca Martin-Rendon
Journal:  Cochrane Database Syst Rev       Date:  2016-12-24

Review 2.  Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology.

Authors:  T Jadczyk; A Faulkner; P Madeddu
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

Review 3.  Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease.

Authors:  Mariann Gyöngyösi; Nabil Dib
Journal:  Nat Rev Cardiol       Date:  2011-05-17       Impact factor: 32.419

4.  Long-Term Outcome of Combined (Percutaneous Intramyocardial and Intracoronary) Application of Autologous Bone Marrow Mononuclear Cells Post Myocardial Infarction: The 5-Year MYSTAR Study.

Authors:  Mariann Gyöngyösi; Georgiana-Aura Giurgea; Bonni Syeda; Silvia Charwat; Beatrice Marzluf; Julia Mascherbauer; Andras Jakab; Abelina Zimba; Márta Sárközy; Noemi Pavo; Heinz Sochor; Senta Graf; Irene Lang; Gerald Maurer; Jutta Bergler-Klein
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

Review 5.  Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials.

Authors:  Ming Hao; Richard Wang; Wen Wang
Journal:  Anal Cell Pathol (Amst)       Date:  2017-01-17       Impact factor: 2.916

6.  Intramyocardial Injection of Stem Cells in Pig Myocardial Infarction Model: The First Trial in Korea.

Authors:  Min Chul Kim; Yong Sook Kim; Wan Seok Kang; Ki Hong Lee; Meeyoung Cho; Moon Hwa Hong; Kyung Seob Lim; Myung Ho Jeong; Youngkeun Ahn
Journal:  J Korean Med Sci       Date:  2017-10       Impact factor: 2.153

Review 7.  The march of pluripotent stem cells in cardiovascular regenerative medicine.

Authors:  Haissam Abou-Saleh; Fouad A Zouein; Ahmed El-Yazbi; Despina Sanoudou; Christophe Raynaud; Christopher Rao; Gianfranco Pintus; Hassan Dehaini; Ali H Eid
Journal:  Stem Cell Res Ther       Date:  2018-07-27       Impact factor: 6.832

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.